Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus Infection

NCT04412863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: VIR-2218
DRUG: pegylated interferon-alfa 2a

Sponsor

Vir Biotechnology, Inc.

Collaborators

[object Object]